ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Search


Volume 1, number 1, 2014
... Preparation of H5N1 inactivated vaccine samples Viruses were grown in the embryonated chicken eggs or cell cultures (Vero, MDCK) as described above. ...
Authors: Mariia Sergeeva, Artem Krokhin, Mikhail Matrosovich, Tatyana Matrosovich, Markus Wolschek, Oleg Kiselev, Julia Romanova
Volume 3, Number 1, 2016
... An analysis of the main advantages and shortcomings of the existing inactivated and live vaccines against the equine influenza viruses (EIVs) is given in this paper. ...
Authors: Kaissar Tabynov
Volume 5, Number 1, 2018
... The broad protection is the important advantage of live-attenuated influenza vaccines when compared to inactivated ones. ...
Authors: Elizaveta Boravleva, Alexandra Gambaryan
Volume 4, Number 1, 2017
... inactivated and live attenuated influenza vaccines. ...
Authors: Julia Romanova
Volume 3, Number 1, 2016
... MDCK cells were cultivated in DMEM/Ham’s F12 (1:1) medium supplemented with 2% of heat inactivated fetal calf serum (FCS) (Gibco). ...
Authors: Andrea Wolkerstorfer, Dietmar Katinger, Julia Romanova
Volume 3, Number 1, 2016
... The basic approaches to as well as challenges of creating such a vaccine are discussed in this review. ...
Authors: Andrej Y. Egorov
Том 1, номер 1, 2014
... Virus with modified HA was less susceptible to freezing stress and showed an increased content of immunocompetent HA in inactivated vaccine preparation compared to the analogous virus with original HA. ...
Authors: М.В. Сергеева, А. Крохин, М. Матросович, Т. Матросович, М. Волшек, О.И. Киселев, Ю.Р. Романова
Том 5, номер 1, 2018
... The broad protection is the important advantage of live-attenuated influenza vaccines when compared to inactivated ones. ...
Authors: Е. Ю. Боравлева, А. С. Гамбарян
Том 4, номер 1, 2017
... inactivated and live attenuated influenza vaccines. ...
Authors: Ю.Р. Романова
Volume 5, Number 1, 2018
... It was shown that immunization with an inactivated influenza vaccine significantly reduces the severity of bacterial superinfection in mice infected with influenza [93 ...
Authors: Andrej Egorov
Volume 3, Number 1, 2016
... The obtained sera (7 animals per group) were treated with the neuraminidase inhibitor (Denka-Seiken, Japan) and tested for the presence of antibodies to the vaccine virus Len17/H6 in HAI test as described ...
Authors: Yulia A. Desheva, Tatiana A. Smolonogina, Galina O. Landgraf, Larisa G. Rudenko
Volume 2, Number 1, 2015
... Strains belonging to clade 1 were similar to A/New Caledonia/20/1999 vaccine strain (Fig. 1). ...
Authors: Mikhail P. Grudinin, Maria M. Pisareva, Andrey B. Komissarov, Anna A. Kosheleva, Zhanna V. Buzitskaya, Marina A. Stukova, Alexandra V. Prokopetz, Daria M. Danilenko, Nadezhda I. Konovalova, Tamara G. Lobova, Anna A. Sominina, Oleg I. Kiselev
Volume 6, Number 1, 2019
... For phylogenetic analysis, we selected Ukrainian and European isolates obtained in the course of the study period as well as vaccine and reference strains. ...
Authors: Svetlana V. Babii, Liudmyla V. Leibenko, Larysa V. Radchenko, Olga S. Golubka, Nataliia V. Teteriuk, Alla P. Mironenko
Volume 2, Number 1, 2015
... Petersburg matched the vaccine strains recommended by the WHO for vaccine composition in the 2012-2013 and 2013-2014 seasons.  ...
Authors: Anna A. Sominina, Maria M. Pisareva, Mikhail P. Grudinin, Mikhail Yu. Eropkin, Nadezhda I. Konovalova, Vera F. Sukhovetskaya, Olga I. Afanasieva, Lubov V. Voloshuk, Andrey B. Komissarov, Zhanna V. Buzitskaya, Artem V. Fadeev, Kirill A. Stolyarov, Elizaveta A. Smorodintseva, Veronika S. Afanasieva, Marina A. Yanina, Vitalii V. Gonchar, Ludmila V. Osidak, Alexey A. Go
Volume 5, Number 1, 2018
... A live intranasal influenza vaccine, which was developed on the basis of the influenza virus with the removed NS1 protein reading frame, has successfully passed clinical trials [ ...
Authors: Kirill A. Vasilyev, Maria A. Yukhneva, Anna-Polina S. Shurygina, Marina A. Stukova, Andrej Y. Egorov
Том 3, номер 1, 2016
... Basic approaches and challenges in creating such a vaccine are discussed in this review. ...
Authors: А.Ю. Егоров
Volume 4, Number 1, 2017
...
A classical way to produce attenuated strains for live influenza vaccine is the reassortment of the epidemic virus ...
Authors: Rustam N. Heydarov, Natalia F. Lomakina, Elizaveta Yu. Boravleva, Ivan S. Kholodilov, Alexandra S. Gambaryan, Vladimir M. Mikhailovich, Eugene E. Fesenko
Volume 2, Number 1, 2015
... It is also evident that in the process of anti-influenza vaccine development it is necessary to consider the possibility of the vaccine’s “genetic” orientation toward large population ...
Authors: O. I. Kiselev, A. B. Komissarov, O.S.Konshina, M.N.Dmitrieva, E.G.Deyeva, T.V.Sologub, V.I.Pokrovskiy